Terms: = Lung cancer AND IDH1, IDP, 3417, ENSG00000138413, IDH, PICD, O75874 AND Diagnosis
20 results:
1. Smokers and risk of hospital death by COVID calculated with SAVANA's natural language processing in the Castilla-La Mancha area.
Godoy R; Benavent Núñez M; Cruz J; López Yepes G; Parralejo Jiménez A; Callejas FJ; Izquierdo JL
Rev Clin Esp (Barc); 2024 Jan; 224(1):34-42. PubMed ID: 38142978
[TBL] [Abstract] [Full Text] [Related]
2. Detecting undetectable - epidemiology, etiology, and diagnosis of carcinoma of unknown primary - systematic review.
Ostojewska J; Wieczorek I; Pachciński O; Zdziennicki W; Burdan F
Folia Med Cracov; 2023 Apr; 63(1):19-37. PubMed ID: 37406274
[TBL] [Abstract] [Full Text] [Related]
3. Occurrence of non-central nervous system cancers during postoperative follow-up of patients who underwent surgery for a WHO grade II glioma: implications for therapeutic management.
Duffau H
J Neurooncol; 2023 Mar; 162(1):237-244. PubMed ID: 36913047
[TBL] [Abstract] [Full Text] [Related]
4. Incidental discovery of acute myeloid leukemia during liquid biopsy of a lung cancer patient.
Nkosi D; Miller CA; Jajosky AN; Oltvai ZN
Cold Spring Harb Mol Case Stud; 2022 Jun; 8(4):. PubMed ID: 35732498
[TBL] [Abstract] [Full Text] [Related]
5. The isocitrate dehydrogenase 1 is a potential prognostic indicator for non-small cell lung cancer patients.
Zhang X; Ma S; Chen Y; Yin Y; Bai W; Tan J; Shi G
Int J Biol Markers; 2021 Dec; 36(4):27-35. PubMed ID: 34761718
[TBL] [Abstract] [Full Text] [Related]
6. Unexpected diagnosis of multiple sclerosing pneumocytomas in a patient with chondrosarcoma of the hand.
Van Laer SL; Vandendriessche A; Somville J; Van Schil PE
BMJ Case Rep; 2021 Jan; 14(1):. PubMed ID: 33495182
[TBL] [Abstract] [Full Text] [Related]
7. The molecular basis of gender disparities in smoking lung cancer patients.
Davuluri S; Bajpai AK; Thirumurugan K; Acharya KK
Life Sci; 2021 Feb; 267():118927. PubMed ID: 33358908
[TBL] [Abstract] [Full Text] [Related]
8. The Clinical Significance of Serum MASP-2 and idh1 in the Early diagnosis of Non-Small Cell lung cancer.
Chen Y; Wu ED; Ma S; Bai WQ; Yin YJ; Shi GL
Clin Lab; 2020 Nov; 66(11):. PubMed ID: 33180422
[TBL] [Abstract] [Full Text] [Related]
9. Association of Clinicopathological Features With Outcome in Chondrosarcomas of the Head and Neck.
Asioli S; Ruengwanichayakun P; Zoli M; Guaraldi F; Sollini G; Greco P; Facco C; Gibertoni D; Jiménez BV; Benini S; Turri-Zanoni M; Pasquini E; Mazzatenta D; Foschini MP; Righi A
Otolaryngol Head Neck Surg; 2021 Apr; 164(4):807-814. PubMed ID: 32928034
[TBL] [Abstract] [Full Text] [Related]
10. Synovial chondrosarcoma: a single-institution experience with molecular investigations and review of the literature.
Gambarotti M; Pacheco M; Ruengwanichayakun P; Silvino Vega Jiménez B; Benini S; Bianchi G; Sbaraglia M; Vanel D; Carretta E; Bertoni F; Franchi A; Dei Tos AP; Righi A
Histopathology; 2020 Sep; 77(3):391-401. PubMed ID: 32506447
[TBL] [Abstract] [Full Text] [Related]
11. Utility of isocitrate dehydrogenase 1 as a serum protein biomarker for the early detection of non-small-cell lung cancer: A multicenter in vitro diagnostic clinical trial.
Sun N; Sun S; Gao Y; Li Y; Lu Z; Yuan Z; Che Y; Huang J; Mao S; Lei Y; Zang R; Li N; Cui W; Qi J; Chen F; Gao J; Wang J; Min R; Chen Y; Shi G; Tan F; He J
Cancer Sci; 2020 May; 111(5):1739-1749. PubMed ID: 32167618
[TBL] [Abstract] [Full Text] [Related]
12. [Value of Serum Tumor Marker Isocitrate Dehydrogenase 1 in the diagnosis of lung cancer].
Xie H; Kong YX; Zhang Q
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2019 Dec; 41(6):813-817. PubMed ID: 31907132
[No Abstract] [Full Text] [Related]
13. Translational value of idh1 and DNA methylation biomarkers in diagnosing lung cancers: a novel diagnostic panel of stage and histology-specificity.
Zang R; Wang X; Jin R; Lei Y; Huang J; Liu C; Zheng S; Zhou F; Wu Q; Sun N; Gao S; He J
J Transl Med; 2019 Dec; 17(1):430. PubMed ID: 31888670
[TBL] [Abstract] [Full Text] [Related]
14. Variation in the Assessment of Immune-Related Adverse Event Occurrence, Grade, and Timing in Patients Receiving Immune Checkpoint Inhibitors.
Hsiehchen D; Watters MK; Lu R; Xie Y; Gerber DE
JAMA Netw Open; 2019 Sep; 2(9):e1911519. PubMed ID: 31532516
[TBL] [Abstract] [Full Text] [Related]
15. Neuroglial Differentiation and Neoplasms in Testicular Germ Cell Tumors Lack Immunohistochemical Evidence of Alterations Characteristic of Their CNS Counterparts: A Study of 13 Cases.
Matoso A; Idrees MT; Rodriguez FJ; Ibrahim J; Perrino CM; Ulbright TM; Epstein JI
Am J Surg Pathol; 2019 Mar; 43(3):422-431. PubMed ID: 30557172
[TBL] [Abstract] [Full Text] [Related]
16. Extraneural metastases in glioblastoma patients: two cases with YKL-40-positive glioblastomas and a meta-analysis of the literature.
Anghileri E; Castiglione M; Nunziata R; Boffano C; Nazzi V; Acerbi F; Finocchiaro G; Eoli M
Neurosurg Rev; 2016 Jan; 39(1):37-45; discussion 45-6. PubMed ID: 26212701
[TBL] [Abstract] [Full Text] [Related]
17. Isocitrate dehydrogenase 1 is a novel plasma biomarker for the diagnosis of non-small cell lung cancer.
Sun N; Chen Z; Tan F; Zhang B; Yao R; Zhou C; Li J; Gao Y; Liu Z; Tan X; Zhou F; He MY; Shao K; Li N; Qiu B; Sun J; Yu Y; Wang S; Zhao Y; Shi X; He J
Clin Cancer Res; 2013 Sep; 19(18):5136-45. PubMed ID: 24046070
[TBL] [Abstract] [Full Text] [Related]
18. Identification of proteomic signatures associated with lung cancer and COPD.
Pastor MD; Nogal A; Molina-Pinelo S; Meléndez R; Salinas A; González De la Peña M; Martín-Juan J; Corral J; García-Carbonero R; Carnero A; Paz-Ares L
J Proteomics; 2013 Aug; 89():227-37. PubMed ID: 23665002
[TBL] [Abstract] [Full Text] [Related]
19. Identification of isocitrate dehydrogenase 1 as a potential diagnostic and prognostic biomarker for non-small cell lung cancer by proteomic analysis.
Tan F; Jiang Y; Sun N; Chen Z; Lv Y; Shao K; Li N; Qiu B; Gao Y; Li B; Tan X; Zhou F; Wang Z; Ding D; Wang J; Sun J; Hang J; Shi S; Feng X; He F; He J
Mol Cell Proteomics; 2012 Feb; 11(2):M111.008821. PubMed ID: 22064513
[TBL] [Abstract] [Full Text] [Related]
20. 5-Hydroxymethylcytosine is strongly depleted in human cancers but its levels do not correlate with idh1 mutations.
Jin SG; Jiang Y; Qiu R; Rauch TA; Wang Y; Schackert G; Krex D; Lu Q; Pfeifer GP
Cancer Res; 2011 Dec; 71(24):7360-5. PubMed ID: 22052461
[TBL] [Abstract] [Full Text] [Related]
